Group One Trading’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-50,018
Closed -$4.25M 7324
2020
Q3
$4.25M Buy
50,018
+18,064
+57% +$913K 0.01% 1023
2020
Q2
$1.13M Sell
31,954
-11,645
-27% -$340K 0.01% 1909
2020
Q1
$588K Buy
+43,599
New +$734K ﹤0.01% 1939
2019
Q4
Sell
-24,873
Closed -$439K 5884
2019
Q3
$330K Sell
24,873
-8,905
-26% -$131K ﹤0.01% 2691
2019
Q2
$469K Buy
33,778
+2,877
+9% +$43.3K ﹤0.01% 2197
2019
Q1
$594K Sell
30,901
-425,671
-93% -$6.86M 0.01% 1808
2018
Q4
$6.51M Buy
456,572
+154,759
+51% +$3.07M 0.06% 397
2018
Q3
$6.29M Buy
301,813
+56,635
+23% +$1.34M 0.05% 469
2018
Q2
$5.8M Sell
245,178
-149,023
-38% -$3M 0.05% 470
2018
Q1
$5.76M Buy
+394,201
New +$6.44M 0.06% 398
2017
Q1
Sell
-58,913
Closed -$298K 5187
2016
Q4
$216K Sell
58,913
-307,394
-84% -$909K ﹤0.01% 2375
2016
Q3
$1.19M Sell
366,307
-95,940
-21% -$268K 0.01% 1165
2016
Q2
$1.07M Buy
+462,247
New +$1.54M 0.01% 1216
2016
Q1
Sell
-343,288
Closed -$772K 5163
2015
Q4
$1.05M Buy
343,288
+323,330
+1,620% +$903K 0.01% 1284
2015
Q3
$34K Buy
+19,958
New +$50.9K ﹤0.01% 3765
2015
Q2
Sell
-59,380
Closed -$243K 5334
2015
Q1
$227K Sell
59,380
-34,503
-37% -$150K ﹤0.01% 2277
2014
Q4
$451K Sell
93,883
-62,137
-40% -$246K 0.01% 1629
2014
Q3
$580K Buy
156,020
+63,525
+69% +$215K 0.01% 1513
2014
Q2
$338K Sell
92,495
-28,297
-23% -$104K 0.01% 1969
2014
Q1
$509K Buy
+120,792
New +$599K 0.01% 1634
2013
Q4
Sell
-53,432
Closed -$238K 5665
2013
Q3
$331K Sell
53,432
-87,992
-62% -$507K 0.01% 1958
2013
Q2
$769K Buy
+141,424
New +$465K 0.02% 1004

Group One Trading's IMMU Position: Q4 2020 in Review

Group One Trading sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,018 shares — an estimated $4.25M sold.

Group One Trading first reported a position in IMMU in Q2 2013 and held it in 22 quarters. The position peaked at $6.51M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Group One Trading reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Group One Trading sold 50,018 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
  • Group One Trading first reported a position in Immunomedics Inc in Q2 2013 and held it in 22 quarters.
  • Group One Trading's Immunomedics Inc position peaked at $6.51M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.